Yale Catriona bought AKRO
July 16, 2025 · Form 4 insider transaction
Yale Catriona bought 10,000 shares of Akero Therapeutics, Inc. at $19.87 per share, a transaction worth $198.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$19.87
Total value
$198.7K
InsiderYale Catriona
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 16, 2025
Filing dateJuly 18, 2025
Shares owned after101,488
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated May 24, 2024, previously adopted by the Reporting Person.